Point-of-care testing (POCT) is essential for the rapid detection of analytes near to the patient, which facilitates better disease diagnosis, monitoring, and management. It enables quick medical decisions, as the diseases can be diagnosed at a very early stage, leading to improved health outcomes for patients by enabling the early start of treatment. The global Point-of-Care Diagnostics market was valued at $21.40 Billion in 2016 and is expected to reach $45.87 Billion by 2022, at a CAGR of 10.0% during the forecast period. Increase in incidence of target diseases and technological advancements and new product launches are the drivers that boost the growth of the market. On the flipside, the high cost of devices and Lack of knowledge on the usage on POC devices are the restraints that hamper the market growth. Increase in POC tests with multiplexing capabilities and a rise in emerging markets are the opportunities for the market.
Research Study Objectives:
Top-down and bottom-up approaches are used to validate the Point of Care Diagnostics Market Size and are used to estimate the size of other dependent submarkets. Key players in the market
Starting from $2700
Starting from $2700
Starting from $2700
Keep up-to-date with our weekly newsletter, Media Pulse.